{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:42:09Z","timestamp":1766580129929},"reference-count":18,"publisher":"Japanese Urological Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5980\/jpnjurol.104.33","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T23:08:23Z","timestamp":1392937703000},"page":"33-37","source":"Crossref","is-referenced-by-count":3,"title":["PATHOLOGICAL COMPLETE RESPONSE TO GEMCITABINE AND CISPLATIN CHEMOTHERAPY FOR ADVANCED UPPER TRACT UROTHELIAL CARCINOMA: A CASE REPORT"],"prefix":"10.5980","volume":"104","author":[{"given":"Masahiro","family":"Matsuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuuichi","family":"Katou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimio","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","unstructured":"1) Audenet F, Yates DR, Cussenot O and Roupret M: The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC). Urol Oncol., doi.org\/10.1016\/j.urolonc.2010.07.016, 2010."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Roupret M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M and Oosterlinck W: European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol, 59, 584-594, 2011.","DOI":"10.1016\/j.eururo.2010.12.042"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A and Arning M: Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol, 23, 4602-4608, 2005.","DOI":"10.1200\/JCO.2005.07.757"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD and Roehrborn CG: Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology, 52, 594-601, 1998.","DOI":"10.1016\/S0090-4295(98)00295-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Corrado F, Ferri C, Mannini D, Corrado G, Bertoni F, Bacchini P, Lelli G, Lieber MM and Song JM: Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis. J Urol, 145, 1159-1163, 1991.","DOI":"10.1016\/S0022-5347(17)38562-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Rey A, Lara PC, Redondo E, Valdes E and Apolinario R: Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival. Cancer, 79, 2178-2185, 1997.","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2178::AID-CNCR16>3.0.CO;2-T"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hall MC, Womack JS, Roehrborn CG, Carmody T and Sagalowsky AI: Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy. J Urol, 160, 703-706, 1998.","DOI":"10.1016\/S0022-5347(01)62763-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Tanji N, Ozawa A, Miura N, Yanagihara Y, Sasaki T, Nishida T, Kikugawa T, Ikeda T, Ochi T, Shimamoto K, Aoki K and Yokoyama M: Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas. Int J Clin Oncol, 15, 369-375, 2010.","DOI":"10.1007\/s10147-010-0069-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Herr HW, Donat SM and Bajorin DF: Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. J Urol, 165, 811-814, 2001.","DOI":"10.1016\/S0022-5347(05)66533-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Sweeney P, Millikan R, Donat M, Wood CG, Radtke AS, Pettaway CA, Grossman HB, Dinney CP, Swanson DA and Pisters LL: Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? J Urol, 169, 2113-2117, 2003.","DOI":"10.1097\/01.ju.0000067601.29966.4a"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Jadvar H, Quan V, Henderson RW and Conti PS: [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma. Int J Clin Oncol, 13, 42-47, 2008.","DOI":"10.1007\/s10147-007-0720-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Patil VV, Wang ZJ, Sollitto RA, Chuang KW, Konety BR, Hawkins RA and Coakley FV: 18F-FDG PET\/CT of transitional cell carcinoma. AJR Am J Roentgenol, 193, W497-504, 2009.","DOI":"10.2214\/AJR.08.1945"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N and Bouchelouche K: Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography\/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol, 45, 122-128, 2011.","DOI":"10.3109\/00365599.2010.544672"},{"key":"14","unstructured":"14) Chen B, Zeng ZC, Wang GM, Zhang L, Lin ZM, Sun LA, Zhu TY, Wu LL, Zhang JY and Ji Y: Radiotherapy may improve overall survival of patients with T3\/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse. BMC Cancer, 11, 297, 2011."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hellenthal NJ, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Bolenz C, Remzi M, Weizer A, Zigeuner R, Bensalah K, Ng CK, Raman JD, Kikuchi E, Montorsi F, Oya M, Wood CG, Fernandez M, Evans CP and Koppie TM: Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol, 182, 900-906, 2009.","DOI":"10.1016\/j.juro.2009.05.011"},{"key":"16"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Matsumura K, Sugimura K, Uchida J, Naganuma T and Nakatani T: Advanced ureteral cancer with complete remission achieved by taxan containing systemic chemotherapy. Int J Urol, 10, 105-107, 2003.","DOI":"10.1046\/j.1442-2042.2003.00578.x"},{"key":"18"}],"container-title":["The Japanese Journal of Urology"],"original-title":["\u30b2\u30e0\u30b7\u30bf\u30d3\u30f3\u30fb\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u5316\u5b66\u7642\u6cd5\u306b\u3066\u75c5\u7406\u5b66\u7684\u5b8c\u5168\u594f\u529f\u3092\u5f97\u305f\u9032\u884c\u6027\u5c3f\u7ba1\u764c\u306e\u4e00\u4f8b"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T22:27:38Z","timestamp":1621549658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/104\/1\/104_33\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.104.33","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}